Standout Papers

Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis 2021 2026 2022 2024275
  1. Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis (2021)
    Thomas Bieber, Eric L. Simpson et al. New England Journal of Medicine

Immediate Impact

1 from Science/Nature 54 standout
Sub-graph 1 of 22

Citing Papers

Atopic dermatitis
2025 Standout
Medical, surgical, and physical treatments for Parkinson's disease
2024 Standout
10 intermediate papers

Works of Bimal Malhotra being referenced

Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis
2021 Standout
Evaluation of Cognitive Function in Healthy Older Subjects Treated with Fesoterodine
2012

Author Peers

Author Last Decade Papers Cites
Bimal Malhotra 187 141 447 419 318 67 1.5k
Brian M. Gilfix 99 201 29 497 58 59 2.0k
Joseph M. Guileyardo 64 42 221 110 47 74 1.8k
Tai‐Lung Cha 43 41 149 98 23 81 1.4k
Khalid M. Naseem 30 41 46 76 25 81 2.1k
Bei Zhou 42 29 10 694 200 67 1.8k
Daniel R. Saltzstein 17 23 732 704 54 86 1.9k
Shan Li 86 70 13 146 45 79 1.6k
Dae Sung Kim 35 11 30 98 38 76 1.7k
Xiangli Cui 118 43 66 56 9 81 1.7k
Vincenzo Favilla 12 37 482 211 40 69 1.3k

All Works

Loading papers...

Rankless by CCL
2026